Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roy Whitfield Insider Profile
4 Followers
Roy Whitfield, Director at Illumina, holds 287.75K shares in Nektar Therapeutics (Ticker: NKTR), holds 13.65K shares in Illumina (Ticker: ILMN), holds 666.08K shares in Incyte (Ticker: INCY).
Profitable Transactions
4 out of 9 Profitable Transactions
Average Return
+72.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Roy Whitfield holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 17, 2017 - Mar 17, 2018
Return:+564.50%
The most profitable trade made by Roy Whitfield
Roy Whitfield's Trading History
Illumina
Aug 15, 2016
Director
Uninformative Sell
668.88K
$1.64M
Nektar Therapeutics
Jun 15, 2023
Director
Uninformative Sell
17.10K
$391.34K
Incyte
Dec 19, 2013
Director
Informative Buy
330.60K
$34.58M
List of latest transactions for each holding click on a transaction to see Roy Whitfield's performance on stock
You May Also Like
Roy Whitfield insider profile FAQ
What is the percentage of profitable transactions made by Roy Whitfield?
The percentage of profitable transactions made by Roy Whitfield is 44%.
What is the average return per transaction made by Roy Whitfield?
The average return per transaction made by Roy Whitfield is 72.70%.
What stocks does Roy Whitfield hold?
Roy Whitfield holds: ILMN, NKTR, INCY stocks.
What was Roy Whitfield’s latest transaction?
Roy Whitfield latest transaction was an Uninformative Sell of $17.10K.
What was Roy Whitfield's most profitable transaction?
Roy Whitfield’s most profitable transaction was an Informative Buy of NKTR stock on March 17, 2017. The return on the trade was 564.50%.
What is Roy Whitfield's role in Illumina?
Roy Whitfield's role in Illumina is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.